ESCALIER BIOSCIENCES
Escalier Biosciences BV is a privately held biopharmaceutical company developing novel small molecule therapeutics that target ROR?t for the treatment of psoriasis and other autoimmune disorders. Escalier's lead topical and oral drug candidates are currently in late stage preclinical studies. Escalier is registered in The Netherlands with offices in Nijmegen, The Netherlands and Encinitas, California.
ESCALIER BIOSCIENCES
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.escalierbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Series B - Escalier Biosciences
New Science Ventures
New Science Ventures investment in Series B - Escalier Biosciences
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Escalier Biosciences
Official Site Inspections
http://www.escalierbio.com Semrush global rank: 6.03 M Semrush visits lastest month: 1.36 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Escalier Biosciences"
Escalier Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Escalier Biosciences BV is a privately held biopharmaceutical company developing novel small molecule therapeutics that target ROR?t …See details»
Escalier Biosciences - Craft
Escalier Biosciences $19 m in total funding,. See insights on Escalier Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Escalier Biosciences - PitchBook
Escalier Biosciences General Information Description. Developer of small molecule therapeutics designed to advance the treatment of autoimmune diseases. The company's therapeutics have increased penetration in the …See details»
Escalier Biosciences - Overview, News & Similar companies
Who is Escalier Biosciences. Escalier Biosciences, BV is a privately held biopharmaceutical company developing novel small molecule therapeutics that target ROR t for the treat ment of …See details»
Escalier Biosciences B.V. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Escalier Biosciences B.V. of Nijmegen, Gelderland. Get the latest business insights from Dun & …See details»
Escalier Biosciences b.V.: Contact Details and Business Profile
Escalier Biosciences b.V. is a Biotechnology, Biotechnology Research, and Pharmaceuticals company located in Encinitas, California with $6.00 Million in revenue and 25 employees. Find …See details»
Escalier Biosciences (Group) - Life-Sciences-Europe.com
Jan 1, 2016 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Escalier - VentureRadar
"Escalier is developing both topical and oral ROR?t inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would …See details»
Escalier Biosciences, Inc. Company Profile | Encinitas, CA ...
Find company research, competitor information, contact details & financial data for Escalier Biosciences, Inc. of Encinitas, CA. Get the latest business insights from Dun & Bradstreet.See details»
Escalier Biosciences B.V. - Company Profile & Staff Directory
Discover Escalier Biosciences B.V. company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get …See details»
Escalier Biosciences - Company Profile - Tracxn
Nov 29, 2024 Escalier Biosciences - Developer of small molecule based therapeutics for the treatment of psoriasis. This company is not active anymore. Raised a total funding of $22.5M …See details»
Escalier Biosciences B.V. - BioCentury Company Profiles - BCIQ
Nov 13, 2018 Escalier Biosciences B.V. - BioCentury Company Profiles for the biopharma industrySee details»
Escalier Biosciences Overview - Salary.com
Discover essential details about Escalier Biosciences, including address, contact, and journey of our company's evolution.See details»
Escalier Biosciences - Products, Competitors, Financials, Employees ...
Escalier Biosciences is developing both topical and oral RORyt inverse agnostics for the treatment of a broad spectrum of psoriasis patients - from the underserved mild-to-moderate …See details»
Escalier | VentureRadar
Website: http://www.escalierbio.com/ Develops both topical and oral ROR?t inverse agonists for psoriasis treatment, using proprietary technology to limit systemic ...See details»
Escalier Biosciences, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Escalier Doses First Patient with ESR-114 and Announces ... - Forbion
Aug 13, 2018 Dr. Kimball is the Medical Director of the Massachusetts General Physician Organization and a Professor of Dermatology at Harvard Medical School. She is also the …See details»
Escalier Doses First Patient with ESR-114 and Announces Clinical ...
Aug 13, 2018 Dr. Kimball is the Medical Director of the Massachusetts General Physician Organization and a Professor of Dermatology at Harvard Medical ... www.escalierbio.com. …See details»
Escalier Doses First Patient with ESR-114 and Announces Clinical ...
Aug 13, 2018 Commences study to assess novel ROR γ t inhibitor for the treatment of psoriasis Recruits key opinion leaders to guide clinical development of its ROR γ t programs. …See details»
Escalier Doses First Patient with ESR-114 and Announces ... - EPICOS
Aug 13, 2018 NIJMEGEN, The Netherlands and ENCINITAS, Calif., Aug. 13, 2018 /PRNewswire/ -- Escalier Biosciences, BV, a privately held biopharmaceutical company and a …See details»